SCHEMBL9967715

SCHEMBL9967715

CC(C)C(C)Sc1ccccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EHMT2 Q96KQ7 1/20 0.52
EHMT1 Q9H9B1 1/20 0.52
APOBEC3G Q9HC16 1/20 0.52
HPGD P15428 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HSD17B10 Q99714 2/20 0.49
ALDH1A1 P00352 6/20 0.43
MAPT P10636 5/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
TSHR P16473 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
LMNA P02545 2/20 0.37
KDM4E B2RXH2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9888690 0.83 EHMT2 (0.56) EHMT2EHMT1APOBEC3GHPGDSMN1; SMN2
SCHEMBL30495965 0.83 EHMT2 (0.56) EHMT2EHMT1APOBEC3GHPGDSMN1; SMN2
SCHEMBL24599713 0.80 EHMT2 (0.59) EHMT2EHMT1APOBEC3GHPGDSMN1; SMN2
SCHEMBL16132722 0.80 EHMT2 (0.59) EHMT2EHMT1APOBEC3GHPGDSMN1; SMN2
SCHEMBL7245352 0.80 EHMT2 (0.48) EHMT2EHMT1APOBEC3GHPGDSMN1; SMN2
SCHEMBL5061383 0.79 EHMT2 (0.52) EHMT2EHMT1APOBEC3GHPGDSMN1; SMN2
SCHEMBL7818128 0.79 EHMT2 (0.52) EHMT2EHMT1APOBEC3GHPGDSMN1; SMN2
SCHEMBL7459671 0.79 EHMT2 (0.52) EHMT2EHMT1APOBEC3GHPGDSMN1; SMN2
SCHEMBL20210238 0.78 HPGD (0.46) EHMT2EHMT1APOBEC3GHPGDSMN1; SMN2
Hydrochloric Acid SCHEMBL10706712 0.78 EHMT2 (0.50) EHMT2EHMT1APOBEC3GHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150173359-A1 SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES BAYER IP GMBH (DE) 2015-06-25 US disclosed
US-20150173359-A1 SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES BAYER IP GMBH (DE) 2015-06-25 US disclosed
US-9006265-B2 Substituted fused pyrimidinones and dihydropyrimidinones BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-04-14 US disclosed
US-9006265-B2 Substituted fused pyrimidinones and dihydropyrimidinones BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-04-14 US disclosed
US-20120157306-A1 Substituted Fused Pyrimidinones and Dihydropyrimidinones BAYER CROPSCIENCE AG (DE) 2012-06-21 US disclosed
US-20120157306-A1 Substituted Fused Pyrimidinones and Dihydropyrimidinones BAYER CROPSCIENCE AG (DE) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150173359-A1 SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES DHPS, FDPS, DPYD EHMT2 3960/4885EHMT1 3115/4885APOBEC3G 3969/4885
US-20120157306-A1 Substituted Fused Pyrimidinones and Dihydropyrimidinones DHPS, FDPS, DPYD EHMT2 3960/4885EHMT1 3115/4885APOBEC3G 3969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.